Latest News and Press Releases

LONDON, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (the “Company” or “Small Pharma”), a neuropharmaceutical company focused on psychedelic-assisted therapies, is pleased to...

-        H.C. Wainwright 23rd Annual Global Investment Conference-        Maxim Group and M-Vest, Advances in Mental Health Virtual Conference LONDON, Sept. 10, 2021 (GLOBE NEWSWIRE) -- Small...

LONDON, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (the “Company” or “Small Pharma”), a neuropharmaceutical company focused on psychedelic-assisted therapies, announces that it...

LONDON, Aug. 27, 2021 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (the “Company” or “Small Pharma”), a neuropharmaceutical company focused on psychedelic-assisted therapies, is pleased to...

Successful completion of listing on TSX Venture Exchange $58 million financing enables potential rapid advancement of Small Pharma’s patent portfolio LONDON, United Kingdom, July 30, 2021 ...

LONDON, June 22, 2021 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (the “Company” or “Small Pharma”) is pleased to announce that it has retained LifeSci Advisors, LLC (“LSA”) to provide...

LONDON, May 07, 2021 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (the “Company” or “Small Pharma”) is pleased to announce that it has retained the services of Generation IACP Inc. (“GIACP”) to...

LONDON, May 07, 2021 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (the “Company” or “Small Pharma”), an IP-led neuropharmaceutical company, is pleased to announce an update on its patent...

VANCOUVER, British Columbia, May 04, 2021 (GLOBE NEWSWIRE) -- Small Pharma Inc. (formerly Unilock Capital Corp.) (TSXV: DMT) (the “Company” or “Small Pharma”) is pleased to announce that the common...

Common Shares Expected to Commence Trading on the TSX Venture Exchange on or about May 6, 2021 Not for distribution to United States newswire services or for release publication, distribution or...